Gene Therapy

LEXINGTON, Mass. & AMSTERDAM | June 19, 2026 uniQure N.V. has announced preliminary six-month follow-up data from the first...

SEONGNAM and SEOUL, South Korea, June 15, 2026 Rznomics Inc., a clinical-stage biopharmaceutical company focused on RNA-based gene therapies,...

COLLEGE STATION, Texas, June 9, 2026 Matica Biotechnology announced an agreement with University Health Network (UHN) to provide cGMP...

MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...

SOUTH SAN FRANCISCO, Calif., June 3, 2026 Tenaya Therapeutics announced new interim data from its ongoing MyPEAK™-1 Phase 1b/2...

SOUTH SAN FRANCISCO, Calif., June 2, 2026 Tenaya Therapeutics announced that it will present new interim clinical data from...

Edinburgh, UK | May 28, 2026 Clinical-stage oncology company Trogenix announced the first patient has been dosed in the...

DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...

SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...

NEWPORT BEACH, Calif., May 20, 2026 CureDuchenne announced a new partnership expansion with Tevard Biosciences to accelerate development of...